Concepedia

Felicia L. Lenzo

FL

Statistics

Publications

18

Citations

929

H-Index

16

Active since

2011

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

Université Paris Cité

Cornell University

Cancer Genetics (United States)

Délégation Paris 5

Felicia L. Lenzo is an author at Roswell Park Comprehensive Cancer Center specializing in oncology, cancer immunotherapy, and immunotherapy.

ORCID

Publications per year

2011–2021

18

Publications

18

Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden

Carl Morrison, Sarabjot Pabla, Jeffrey M. Conroy et al. · Journal for ImmunoTherapy of Cancer · 2018 · 151 citations · Full text

, , +17

Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients

Sarabjot Pabla, Jeffrey M. Conroy, Mary Nesline et al. · Journal for ImmunoTherapy of Cancer · 2019 · 107 citations · Full text

, , +17

Hyper-mitogenic drive coexists with mitotic incompetence in senescent cells

Olga V. Leontieva, Felicia L. Lenzo, Zoya N. Demidenko et al. · Cell Cycle · 2012 · 91 citations · Full text

, , +17

Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors

Jeffrey M. Conroy, Sarabjot Pabla, Mary Nesline et al. · Journal for ImmunoTherapy of Cancer · 2019 · 90 citations · Full text

, , +17

Analytical Validation of a Next-Generation Sequencing Assay to Monitor Immune Responses in Solid Tumors

Jeffrey M. Conroy, Sarabjot Pabla, Sean T. Glenn et al. · Journal of Molecular Diagnostics · 2017 · 87 citations

, , +17

1–5 of 18